The importance of cytogenetics in polycythemia vera, primary myelofibrosis and essential thrombocythemia

Revista Brasileira de Hematologia e Hemoterapia

Volumn 33, Issue 6, 2011, Pages 401-402

  Conchon, Monika ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856353050     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.5581/1516-8484.20110110     Document Type: Article

References (6)

1. Santos LC, Ribeiro JC, Silva NP, Cerutti J, Silva MR, Chauffaille ML. Cytogenetics, JAK2 and MPL mutations in polycythemia vera, primary myelofibrosis and essential thrombocythemia. Rev Bras Hematol Hemoter. 2011;33(6):417-24.
2. Barbui T, Barosi G, Birgegard G, Cervantes F, Finazzi G, Griesshammer M, Harrison C, Hasselbalch HC, Hehlmann R, Hoffman R, Kiladjian JJ, Kröger N, Mesa R, McMullin MF, Pardanani A, Passamonti F, Vannucchi AM, Reiter A, Silver RT, Verstovsek S, Tefferi A; European LeukemiaNet. Philadelphianegative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet. J Clin Oncol. 2011;29(6):761-70. Comment in: J Clin Oncol. 2011;29(18):e564-5.
3. Panani AD. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications. Cancer Lett. 2007;255(1):12-25.
4. Tefferi A. Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol. 2011;86(3):292-301.
5. Constantinescu SN. Molecular basis of myeloproliferative neoplasms. Hematology Education [Internet. 2011[cited 2011 Aug 24];5:244-54. Paper presented in: 16° Congress of the European Hematology Association; 2011 June 9-12. London: European Hematology Association. Available from: http://www.ehaweb.org/assets/Education-Book-PDF/EHA16-Education-Book.pdf
6. Tefferi A, Noel P, Hanson CA. Uses and abuses of JAK2 and MPL mutation tests in myeloproliferative neoplasms a paper from the 2010 William Beaumont hospital symposium on molecular pathology. J Mol Diagn. 2011;13(5):461-6.